Who owns Neurocrine Biosciences?

Key details on Neurocrine Biosciences (Ticker: NBIX)

Who owns Neurocrine Biosciences?

Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.

Fund Name Number of Shares Share Valuation As Of
FMR 12.93M $731.40M Dec. 31, 2015
T. Rowe Price Associates 9.63M $544.98M Dec. 31, 2015
Vanguard 5.94M $336.09M Dec. 31, 2015
BVF 5.93M $50.40M Dec. 31, 2011
BlackRock Fund Advisors 3.17M $179.35M Dec. 31, 2015
BB Biotech AG 3.12M $176.59M Dec. 31, 2015
PointState Capital 2.63M $104.57M March 31, 2015
OrbiMed Advisors 2.51M $142.27M Dec. 31, 2015
Perceptive Advisors 2.50M $141.21M Dec. 31, 2015
Westfield Capital Management Company 2.29M $90.87M March 31, 2015
VHCP Management 2.22M $16.62M Dec. 31, 2012
Franklin Resources 2.20M $32.71M June 30, 2014
Visium Asset Management 2.20M $124.56M Dec. 31, 2015
Inves 2.18M $86.91M Sept. 30, 2015
STATE STREET CORPORATION 2.18M $123.46M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 2.14M $84.96M March 31, 2015

Who sold Neurocrine Biosciences?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wellington Management Company Dec. 31, 2010 2.17M $16.59M